Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10

Affiliations

• ¹ Statisticon AB, Uppsala, Sweden.
• ² University of North Carolina at Chapel Hill, Chapel Hill, NC.
• ³ Baim Institute for Clinical Research, Boston, MA.
• ⁴ Georgetown University Medical Center, Washington, DC.
• ⁵ University of Liverpool, Liverpool, U.K.
• ⁶ University of Leicester, Leicester, U.K.
• ⁷ Ulm University, Ulm, Germany.
• ⁸ Karolinska Institutet, Stockholm, Sweden.
• ⁹ University of Oslo and Oslo University Hospital, Oslo, Norway.
• ¹⁰ Steno Diabetes Center Copenhagen, Gentofte, Denmark.
• ¹¹ National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
• ¹² AstraZeneca, Wilmington, DE.
• ¹³ AstraZeneca, Gothenburg, Sweden.
• ¹⁴ AstraZeneca, Cambridge, U.K.
• ¹⁵ Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, MO [email protected].